Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
McKesson
Moodys
Boehringer Ingelheim
Medtronic

Last Updated: January 22, 2020

DrugPatentWatch Database Preview

Litigation Details for Abbott Labs v. Baxter Phar Prod Inc (N.D. Ill. 2000)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Abbott Labs v. Baxter Phar Prod Inc (N.D. Ill. 2000)

Docket   Start Trial Date Filed 2000-09-27
Court District Court, N.D. Illinois Date Terminated 2002-03-26
Cause 35:271 Patent Infringement Assigned To Ronald A. Guzman
Jury Demand Both Referred To
Parties ABBOTT LABORATORIES; BAXTER HEALTHCARE CORPORATION; BAXTER PHARMACEUTICAL PRODUCTS, INC.; CENTRAL GLASS COMPANY LTD.
Patents 5,990,176; 6,074,668
Attorneys David T. Pritikin; Edward L. Foote; Hugh Allen Abrams; Marc Andrew Cavan; Marc Ethan Raven; Marie A. Lona; Peggy M. Balesteri; R. Mark McCareins; Raymond C. Perkins; Russell E. Cass; Sharon E. Jones; Thomas S. Borecki; William Hans Baumgartner , Jr.
Firms Baxter Healthcare Corporation; Jones Diversity Inc.; Ropes & Gray LLP; Winston and Strawn LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Abbott Labs v. Baxter Phar Prod Inc
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Abbott Labs v. Baxter Phar Prod Inc (N.D. Ill. 2000)

Date Filed Document No. Description Snippet Link To Document
2000-09-27 1 complaint States Patent and Trademark Oftice (“PTO”) duly and legally issued United States Patent No. 5,990,176 (“the… COUNT I -INFRINGEMENT OF UNITED STATES PATENT NO. 5,990,176 (Plaintiffs: Abbott and Central Glass) …Plaintiffs pray: A. That U.S. Patent No_._ 5,990,176 be judged valid, enforceable, and infringed by Defendants…expiration of the ‘176 Patent was an act that infringes the claims of the ‘176 Patent. WHEREFORE, Plaintiffs…and legally issued United States Patent No. 6,074,668 (“the ‘668 Patent” , entitled “Container For An Inhalation External link to document
2002-03-26 58 minutes - miscellaneous by Baxter of Abbott’s patent, U.S. Patent No. 5,990, 176 (the “'176 patent”) in Count I. The product…infringement of U.S. Patent No. 6,074,668 (“'668 Patent”). The '668 patent covers a container for…during the lives of Abbott’s '176 patent and Abbott’s 668 patent DISCUSSION We will dismiss Abbott’…product covered by the '176 patent is an anesthetic inhalant, which Abbott sells under the trademark…involve Baxter’s alleged infringement of the '176 patent. Thus, a live controversy exists as to Count I External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Baxter
Express Scripts
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.